Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Countering Development of Resistance to Treatment in AML By Targeting Metabolic Adaptations

Marta Romo-González, Tanima Kundu, M. Elena Diaz-Rubio, Xiaoyang Su, Matthew J McBride, Christina Glytsou

Blood (2024) 144 (Supplement 1): 5748.

https://doi.org/10.1182/blood-2024-211612

Published: 2024

Journal Articles

Therapeutic Effects and Metabolic Rewiring upon Glutaminase Loss in T-ALL

Victoria da Silva-Diz, Maya Aleksandrova, Amartya Singh, Eric Chiles, Xiaoyang Su, Daniel Herranz

Blood (2023) 142 (Supplement 1): 1448.

https://doi.org/10.1182/blood-2023-190974

Published: 2023

Journal Articles

Sirt1 Is a Novel Therapeutic Target in T-ALL

Olga Lancho, Amartya Singh, Victoria da Silva-Diz, Patricia Renck Nunes, Luca Tottone, Shirley Luo, Maya Aleksandrova, Xiaoyang Su, Hossein Khiabanian, Daniel Herranz

Blood (2021) 138 (Supplement 1): 2221.

https://doi.org/10.1182/blood-2021-153950

Published: 2021

Journal Articles

A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia

Victoria da Silva-Diz, Bin Cao, Olga Lancho, Eric Chiles, Amer Alasadi, Maya Aleksandrova, Shirley Luo, Amartya Singh, Hanlin Tao, David Augeri, Sonia Minuzzo, Stefano Indraccolo, Hossein Khiabanian, Xiaoyang Su, Shengkan Jin, Daniel Herranz

Blood (2021) 138 (15): 1317–1330.

https://doi.org/10.1182/blood.2020008955

Published: 2021

Includes: Supplemental data

Journal Articles

Identification of FASN-Dependent Onco-Metabolic Regulation of the Pentose Phosphate Pathway (PPP) and Nucleotide Metabolism in Non-Hodgkin Lymphoma (NHL)

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Xiaoyang Su, PhD, Ying Chen, PhD, Maisarah Mokhtar, B.S, Gregory Dolnikowski, Frederick Lansigan, MD, William B Kinlaw, III, MD, Sandeep Dave, MD, Andrew M. Evens, DO, MSc

Blood (2019) 134 (Supplement_1): 1573.

https://doi.org/10.1182/blood-2019-126382

Published: 2019

NARROW

Countering Development of Resistance to Treatment in AML By Targeting Metabolic Adaptations

Therapeutic Effects and Metabolic Rewiring upon Glutaminase Loss in T-ALL

Sirt1 Is a Novel Therapeutic Target in T-ALL

A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia

Identification of FASN-Dependent Onco-Metabolic Regulation of the Pentose Phosphate Pathway (PPP) and Nucleotide Metabolism in Non-Hodgkin Lymphoma (NHL)

Email alerts

ASH Publications

American Society of Hematology

Countering Development of Resistance to Treatment in AML By Targeting Metabolic Adaptations

Therapeutic Effects and Metabolic Rewiring upon Glutaminase Loss in T-ALL

Sirt1 Is a Novel Therapeutic Target in T-ALL

A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia

Identification of FASN-Dependent Onco-Metabolic Regulation of the Pentose Phosphate Pathway (PPP) and Nucleotide Metabolism in Non-Hodgkin Lymphoma (NHL)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only